BioSpace News Archive

The landscape of cell culture growth is generating demand for serum free media. And, this is all set to bring about a notable growth in the global serum free media market.

Polyphor AG published the invitation to its Extraordinary General Meeting on October 28, 2021 and announced financial results for the first half of 2021.

Fact.MR’s latest study examines key trends prevalent across the viral disease diagnosis market. It classifies the market in terms of product type, virus, and end use.

Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, will be presenting new preclinical in vivo data on improving oligo delivery to the liver in an online poster presentation at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society, held virtually from September 26th to 29th, 2021.

TYME Technologies, Inc. announced that the first patient has been dosed in the Phase II OASIS trial in patients with metastatic hormone receptor positive, human epidermal growth factor receptor 2 negative (“HR+/HER2-“) breast cancer

Anavex Life Sciences Corp. announced that effective as of market open today, September 27, 2021, its shares of common stock have been approved for uplisting to the NASDAQ Global Select Market® and will continue trading under its current ticker symbol AVXL.

Ocuphire Pharma, Inc. announced that Mina Sooch, President and Chief Executive Officer will be presenting corporate overviews at the Benzinga Healthcare Small Cap Conference on Wednesday, September 29th.

Landos Biopharma, Inc., a late-clinical-stage biopharmaceutical company utilizing its LANCE® advanced A.I. platform to develop novel therapeutics for patients with autoimmune diseases, announced that Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer of Landos, will participate in the Truist Securities CEO Fireside Chat Series.

Seegene Inc., a leading biotechnology firm specializing in molecular diagnostics, is unveiling a fully automated PCR testing system at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo to be held on September 26-30, 2021, in Atlanta, GA, USA.

Omega Therapeutics, Inc. today announced that Mahesh Karande , President and Chief Executive Officer, will participate in a fireside chat at the Chardan Virtual 5th Annual Genetic Medicines Conference on Monday, October 4, 2021 at 8:30 a.m. ET.